» Articles » PMID: 29137642

Effects of MRNA Secondary Structure on the Expression of HEV ORF2 Proteins in Escherichia Coli

Overview
Publisher Biomed Central
Date 2017 Nov 16
PMID 29137642
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Viral protein expression in Escherichia coli (E. coli) is a powerful tool for structural/functional studies as well as for vaccine and diagnostics development. However, numerous factors such as codon bias, mRNA secondary structure and nucleotides distribution, have been indentified to hamper this heterologous expression.

Results: In this study, we combined computational and biochemical methods to analyze the influence of these factors on the expression of different segments of hepatitis E virus (HEV) ORF 2 protein and hepatitis B virus surface antigen (HBsAg). Three out of five HEV antigens were expressed while all three HBsAg fragments were not. The computational analysis revealed a significant difference in nucleotide distribution between expressed and non-expressed genes; and all these non-expressing constructs shared similar stable 5'-end mRNA secondary structures that affected the accessibility of both Shine-Dalgarno (SD) sequence and start codon AUG. By modifying the 5'-end of HEV and HBV non-expressed genes, there was a significant increase in the total free energy of the mRNA secondary structures that permitted the exposure of the SD sequence and the start codon, which in turn, led to the successful expression of these genes in E. coli.

Conclusions: This study demonstrates that the mRNA secondary structure near the start codon is the key limiting factor for an efficient expression of HEV ORF2 proteins in E. coli. It describes also a simple and effective strategy for the production of viral proteins of different lengths for immunogenicity/antigenicity comparative studies during vaccine and diagnostics development.

Citing Articles

Decoding stoichiometric protein synthesis in through translation rate parameters.

Irshad I, Sharma A Biophys Rep (N Y). 2023; 3(4):100131.

PMID: 37789867 PMC: 10542608. DOI: 10.1016/j.bpr.2023.100131.


Synonymous and Nonsynonymous Substitutions in Dictyostelium discoideum Ammonium Transporter Are Necessary for Functional Complementation in Saccharomyces cerevisiae.

Densi A, Iyer R, Bhat P Microbiol Spectr. 2023; :e0384722.

PMID: 36840598 PMC: 10100761. DOI: 10.1128/spectrum.03847-22.


Design and development of a chimeric vaccine candidate against zoonotic hepatitis E and foot-and-mouth disease.

Behloul N, Baha S, Liu Z, Wei W, Zhu Y, Rao Y Microb Cell Fact. 2020; 19(1):137.

PMID: 32653038 PMC: 7352093. DOI: 10.1186/s12934-020-01394-1.


Development of BacMam Induced Hepatitis E Virus Replication Model in Hepatoma Cells to Study the Polyprotein Processing.

Kumar M, Hooda P, Khanna M, Patel U, Sehgal D Front Microbiol. 2020; 11:1347.

PMID: 32625196 PMC: 7315041. DOI: 10.3389/fmicb.2020.01347.


High-resolution modeling of the selection on local mRNA folding strength in coding sequences across the tree of life.

Peeri M, Tuller T Genome Biol. 2020; 21(1):63.

PMID: 32151272 PMC: 7063772. DOI: 10.1186/s13059-020-01971-y.


References
1.
Sato K, Hamada M, Asai K, Mituyama T . CENTROIDFOLD: a web server for RNA secondary structure prediction. Nucleic Acids Res. 2009; 37(Web Server issue):W277-80. PMC: 2703931. DOI: 10.1093/nar/gkp367. View

2.
Elghanam M, Attia A, Shoeb H, Hashem A . Expression and purification of hepatitis B surface antigen S from Escherichia coli; a new simple method. BMC Res Notes. 2012; 5:125. PMC: 3392745. DOI: 10.1186/1756-0500-5-125. View

3.
Goodman D, Church G, Kosuri S . Causes and effects of N-terminal codon bias in bacterial genes. Science. 2013; 342(6157):475-9. DOI: 10.1126/science.1241934. View

4.
Trepo C, Chan H, Lok A . Hepatitis B virus infection. Lancet. 2014; 384(9959):2053-63. DOI: 10.1016/S0140-6736(14)60220-8. View

5.
Blasco-Perrin H, Abravanel F, Blasco-Baque V, Peron J . Hepatitis E, the neglected one. Liver Int. 2016; 36 Suppl 1:130-4. DOI: 10.1111/liv.13014. View